Diffusion and mathematical modeling of release profiles from nanocarriers

被引:93
作者
Cruz, L
Soares, LU
Dalla Costa, T
Mezzalira, G
da Silveira, NP
Guterres, SS
Pohlmann, AR
机构
[1] Univ Fed Rio Grande Sul, Inst Quim, Programa Posgrad Quim, BR-91501970 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande Sul, Fac Pharm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
关键词
nanoparticles; nanocapsules; indomethacin; alkaline hydrolysis; poly(epsilon-caprolactone); indomethacin ethyl ester;
D O I
10.1016/j.ijpharm.2006.01.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this work was to establish models and to differentiate the kinetic release behavior of drug models from nanocapsules, nanoemulsion and nanospheres by physico-chemical characterization and release experiments. SAXS analysis showed that the polymer is organized in the nanocapsules, while in the nanospheres the sorbitan monostearate is organized and acts as an impurity of the poly(epsilon--caprolactone) suggesting that constituents in these nanocarriers are differently organized. Formulations presented particle sizes ranging from 178 to 297 nm, probe content from 0.981 to 0.997 mg/mL, pH values from 4.90 to 5. 10 and zeta potential from -37.9 to -51.9 mV. The kinetic experiments showed that the nanostructures present similar behaviors when the probe is adsorbed on the nanocarriers (indomethacin-loaded formulations). However, when the probe is entrapped within the nanocarriers (indomethacin ethyl ester-loaded formulations), nanocapsules, nanospheres and nanoemulsion presented different kinetic behaviors. Mathematical modeling of the release profiles was conducted, showing that the presence of the polymer increases the half-lives of the burst phases (5.9, 4.4 and 2.7 min) while the presence of the oil increases the half-lives of the sustained phases (288.8, 87.7 and 147.5 min) for nanocapsules, nanospheres and nanoemulsion, respectively. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 43 条
  • [21] Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheres
    Jeong, JC
    Lee, J
    Cho, K
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 92 (03) : 249 - 258
  • [22] Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
    Jung, T
    Kamm, W
    Breitenbach, A
    Kaiserling, E
    Xiao, JX
    Kissel, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 147 - 160
  • [23] Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors
    Kalgutkar, AS
    Marnett, AB
    Crews, BC
    Remmel, RP
    Marnett, LJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (15) : 2860 - 2870
  • [24] Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
  • [25] Lopes E, 2000, PHARMAZIE, V55, P527
  • [26] DESIGN OF NEW FORMULATIONS FOR TOPICAL OCULAR ADMINISTRATION - POLYMERIC NANOCAPSULES CONTAINING METIPRANOLOL
    LOSA, C
    MARCHALHEUSSLER, L
    ORALLO, F
    JATO, JLV
    ALONSO, MJ
    [J]. PHARMACEUTICAL RESEARCH, 1993, 10 (01) : 80 - 87
  • [27] MAGENHEIM B, 1991, S T P PHARM SCI, V4, P221
  • [28] Montasser I, 2000, J Pharm Belg, V55, P155
  • [29] Müller CR, 2001, PHARMAZIE, V56, P864
  • [30] Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications
    Pinto-Alphandary, H
    Andremont, A
    Couvreur, P
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 13 (03) : 155 - 168